M2care is a venture studio focused on HealthTech, operating as a team of entrepreneur-investors. They finance, operate, and develop innovations aimed at addressing significant health challenges. Unlike incubators or accelerators, M2care invests its own funds and engages operationally in startups, acting as entrepreneurs in residence alongside project leaders. Their approach involves testing project feasibility, creating startups from innovations, investing funds up to Series A, de-risking projects, allocating human resources, recruiting talent, and facilitating market access. M2care's proactive and collaborative method aims to build solid and promising startups ready to tackle market challenges and seize growth opportunities. They select innovations and build the startups of the future. M2care sources HealthTech "rare gems" to transform them into high-performing startups. Before committing to creating a startup and investing, M2care dedicates time to explore the technological assets, risks, and opportunities of each project. They anticipate challenges related to intellectual property, clinical and regulatory developments, industrialization, and market access. Their focus is on constructing the startup by elaborating a detailed development plan, a clear roadmap, securing necessary funding, and assembling a competent team to execute the project. This is done with active support from an ecosystem of industry experts, entrepreneurs, large corporations, academic networks, and healthcare professionals. M2care invests financially and dedicates time and expertise to the startups, transforming human capital into value. They build a cohesive team with project leaders, providing essential skills to launch and develop initial project stages, and can assume the role of CEO as needed. They remain operationally involved until Series A, adapting to the startup's specific needs and preparing for operational transition. M2care finances the earliest development stages, leveraging non-dilutive funding to establish a solid foundation for future growth. Finally, M2care values each project milestone and identifies suitable co-investors among seed and Series A funds to finance further development phases. They also identify potential acquirers early to prepare strategic exits, ensuring startups are ready to capitalize on market opportunities and maximize impact.
Preferred startup development maturity for initial funding deployment.
HealthTech, Deeptech, Medical Devices, Digital Medical Devices, Neuroimaging, Therapeutics
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
